HELSINN INTERNATIONAL (IRE) LIMITED

Helsinn International (Ire) Limited is a global pharmaceutical company dedicated to supportive care for patients living with cancer and chronic diseases. Guided by core values of integrity, passion and quality, Helsinn's mission is to improve patients' health and quality of life worldwide, delivering high-quality products that ease the burdens of treatment.

The company operates a unique integrated licensing model, building, launching and commercialising solid brands across the supportive-care spectrum. Its comprehensive technical organisation blends internal expertise with external collaborations, covering everything from drug development and regulatory affairs to manufacturing and supply-chain management. A state-of-the-art manufacturing plant in Ireland underpins both routine production and the creation of new formulations, turning strategic ideas into real-world medicines.

Beyond its product portfolio, Helsinn is committed to responsible growth. It has maintained carbon-neutral status for five consecutive years and embeds sustainability, ethics and strong governance into its business strategy, believing that positive societal impact strengthens trust and fuels innovation.